Početna › Leukemija › Alabama › Birmingham
Kliničke studije za Leukemija u gradu Birmingham, AL
10 studija za Leukemija traži sudionike na lokacijama u gradu Birmingham i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
U tijeku regrutacijaFaza 3
- Quetzal Site 16, Birmingham
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
U tijeku regrutacijaFaza 2
- University of Alabama - Birmingham, Birmingham
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
U tijeku regrutacijaFaza 2
- The University of Alabama at Birmingham, Birmingham
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
U tijeku regrutacijaFaza 1/2
- Dren Investigational Site, Birmingham
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
U tijeku regrutacijaOpažajna studija
- Children's Hospital of Alabama, Birmingham
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
U tijeku regrutacijaFaza 1
- University of Alabama at Birmingham, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
- Massive Bio SYNERGY-AI site, Birmingham
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
U tijeku regrutacijaFaza 2
- University of Alabama at Birmingham, Birmingham
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
U tijeku regrutacijaFaza 2
- University of Alabama at Birmingham, Birmingham
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
U tijeku regrutacijaFaza 1
- University of Alabama at Birmingham, Birmingham
Studije za Leukemija u drugim gradovima
- Houston, TX28 studija
- Boston, MA25 studija
- New York City, NY19 studija
- Los Angeles, CA16 studija
- Chicago, IL16 studija
- Durham, NC13 studija
- Baldwin Park, CA12 studija
- Columbus, OH12 studija
- Nashville, TN12 studija
- Philadelphia, PA12 studija
- Milwaukee, WI11 studija
- Atlanta, GA11 studija
Ostale studije u gradu Birmingham
- Rak (sve vrste)30 studija
- Rak dojke24 studija
- Debljina23 studija
- Rak jajnika23 studija
- Nemikrocelularni karcinom pluća22 studija
- Akutna mijeloična leukemija21 studija
- Multipli mijelom18 studija
- KOPB17 studija
- Kardiovaskularne bolesti17 studija
- Prekomjerna tjelesna masa16 studija
- Rak endometrija16 studija
- Dijabetes tipa 216 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.